InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Kenney Richard T, Directeur Médical. Director active across 1 companies, notably Sonnet BioTherapeutics Holdings, Inc.. Cumulatively, 4 filings have been published. Total volume traded: €63k. The latest transaction was filed on 9 June 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
€18,96215,000 shares@ €1.264259.8% of flow
Common Stock
SEC:0001493152-21-013939·
Ideal exit: 6 Mar 2022 (T+270)
€18,96215,000 shares@ €1.264229.9% of flow
Common Stock
SEC:0001493152-21-013939:0·
Ideal exit: 6 Mar 2022 (T+270)
€12,73310,000 shares@ €1.273340.2% of flow
Common Stock
SEC:0000905718-21-000714·
Ideal exit: 13 Feb 2022 (T+270)
€12,73310,000 shares@ €1.273320.1% of flow
Common Stock
SEC:0000905718-21-000714:0·
Ideal exit: 13 Feb 2022 (T+270)
4 of 4 declarations
About Kenney Richard T
Richard T. Kenney is the Chief Medical Officer at Sonnet BioTherapeutics Holdings, Inc. He oversees the company's medical and research initiatives, contributing to its development in the biopharmaceutical sector.
